Teleflex announces strategic divestitures of three business units, completes BIOTRONIK acquisition

Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read

Key Changes

• high

  Teleflex entered agreements to divest Acute Care, Interventional Urology, and OEM businesses, representing a major portfolio realignment. The company is incurring separation costs to prepare these units for sale.

  Item 2.02 verify on EDGAR →
• high

  Teleflex acquired BIOTRONIK's Vascular Intervention business, expanding its vascular capabilities. Pro forma financials treat the deal as if it closed January 1, 2025.

  Item 2.02 verify on EDGAR →
• medium

  The company increased reserves for Italian payback measures covering prior years, excluded from adjusted earnings as a non-recurring regulatory charge.

  Item 2.02 verify on EDGAR →